BE891585A - 5 ALPHA-ANDROSTANE-17 BETA-CARBOXYLATES AND 5 BETA-ANDROSTANE-17 BETA-CARBOXYLATES, THEIR PREPARATION AND THEIR USE - Google Patents

5 ALPHA-ANDROSTANE-17 BETA-CARBOXYLATES AND 5 BETA-ANDROSTANE-17 BETA-CARBOXYLATES, THEIR PREPARATION AND THEIR USE

Info

Publication number
BE891585A
BE891585A BE0/206909A BE206909A BE891585A BE 891585 A BE891585 A BE 891585A BE 0/206909 A BE0/206909 A BE 0/206909A BE 206909 A BE206909 A BE 206909A BE 891585 A BE891585 A BE 891585A
Authority
BE
Belgium
Prior art keywords
beta
androstane
carboxylates
alpha
preparation
Prior art date
Application number
BE0/206909A
Other languages
French (fr)
Inventor
D Ayer
C Schlagel
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BE891585A publication Critical patent/BE891585A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/206909A 1980-12-22 1981-12-22 5 ALPHA-ANDROSTANE-17 BETA-CARBOXYLATES AND 5 BETA-ANDROSTANE-17 BETA-CARBOXYLATES, THEIR PREPARATION AND THEIR USE BE891585A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21929380A 1980-12-22 1980-12-22

Publications (1)

Publication Number Publication Date
BE891585A true BE891585A (en) 1982-06-22

Family

ID=22818692

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/206909A BE891585A (en) 1980-12-22 1981-12-22 5 ALPHA-ANDROSTANE-17 BETA-CARBOXYLATES AND 5 BETA-ANDROSTANE-17 BETA-CARBOXYLATES, THEIR PREPARATION AND THEIR USE

Country Status (8)

Country Link
JP (1) JPS57131000A (en)
BE (1) BE891585A (en)
DE (1) DE3149475A1 (en)
FR (1) FR2496668A1 (en)
GB (1) GB2089808A (en)
IT (1) IT1142142B (en)
NL (1) NL8105455A (en)
ZA (1) ZA817929B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
SE8501693D0 (en) * 1985-04-04 1985-04-04 Draco Ab NOVEL 16,17-ACETALSUBSTITUTED ANDROSTANE-17BETA-CARBOXYLIC ACID ESTERS
ES2041245T3 (en) * 1985-10-23 1993-11-16 The Upjohn Company ANGIO-STATIC STEROIDS.
KR101591482B1 (en) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 - non-hormonal steroid modulators of nf-b for treatment of disease
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc Non-hormonal steroid modulators of nf- kappa b for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
FR2477156A1 (en) * 1980-02-15 1981-09-04 Glaxo Group Ltd ANDROSTANE CARBOTHIOATES, THEIR PREPARATION PROCESS, COMPOUNDS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
FR2496668A1 (en) 1982-06-25
IT8125692A0 (en) 1981-12-18
DE3149475A1 (en) 1982-07-15
GB2089808A (en) 1982-06-30
NL8105455A (en) 1982-07-16
ZA817929B (en) 1982-10-27
IT1142142B (en) 1986-10-08
JPS57131000A (en) 1982-08-13

Similar Documents

Publication Publication Date Title
FR2504931B1 (en) MODIFIED IONOMERES, THEIR PREPARATION AND THEIR USE
BE884300A (en) AMIDES, THEIR PREPARATION AND THEIR USE
BE879586A (en) PHOSPHINYLALCANOYL PROLINES, THEIR PREPARATION AND THEIR USE
LU81439A1 (en) OCTAHYDRO-PYRAZOLO (3,4-G) QUINOLEINES AND THEIR THERAPEUTIC USE
MA19845A1 (en) NEW PIPERIDINAMINES AND THEIR PREPARATION
BE890380A (en) THERMOPLASTIC FILMS, THEIR PREPARATION AND THEIR USE
FR2573083B1 (en) ORGANOSILOXANE-OXYALKYLENE COPOLYMERS, THEIR PREPARATION AND THEIR USE
BE889401A (en) 10-ALCYNYL STEROIDS, THEIR PREPARATION AND THEIR USE
FI822164A0 (en) CYLINDERLAOS-NYCKELKOMBINATION, LAOSCYLINDER AND NYCKEL FOER DENNA KOMBINATION
BE896993A (en) FACTORS 1,2,3,4 and 5 OF TEICHOMYCIN A2, THEIR PREPARATION AND THEIR USE
BE882601A (en) MERCAPTOACYLDIPEPTIDES, THEIR PREPARATION AND THEIR USE
FR2494689B1 (en) XANTHATES, THEIR PREPARATION AND THEIR USE
BE896018A (en) PYRROLACETIC AMIDES, THEIR PREPARATION AND THEIR USE
FR2511003B1 (en) ERGOPEPTIDE ALACALOIDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
OA07332A (en) Oximes-ethers, their preparation and use.
BE855992A (en) TESTOTERONE 5 ALPHA-REDUCTASE INHIBITORS, THEIR PREPARATION AND THEIR USE
BE871807A (en) 4-QUINOLYL-GUANIDINES, THEIR PREPARATION AND THEIR USE
BE889100A (en) TAURINE DERIVATIVES, THEIR PREPARATION AND THEIR USE
BE887323A (en) 17ALPHA-ACYLOXY-5 BETA-CORTICOIDES AND 17ALPHA-ACYLOXY-5ALPHA-CORTICOIDES, THEIR PREPARATION AND THEIR USE
BE885117A (en) 3-AMINO-OXAZOLIDIN-2-ONES, THEIR PREPARATION AND THEIR USE
BE882010A (en) TETRAHYDROBENZOTHIAZOLYLIMIDAZOLIDINONES AND THEIR USE
BE891585A (en) 5 ALPHA-ANDROSTANE-17 BETA-CARBOXYLATES AND 5 BETA-ANDROSTANE-17 BETA-CARBOXYLATES, THEIR PREPARATION AND THEIR USE
BE880282A (en) 4,1-BENZOXAZEPINES AND 4,1-BENZOTHIAZEPINES
BE866728A (en) 1,2,4-TRIAZOLES, THEIR PREPARATION AND THEIR USE
BE894056A (en) 2-OXO-AZETIDINES, THEIR PREPARATION AND THEIR USE

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THE UPJOHN CY

Effective date: 19861231